Trivitron develops kit for detection of Monkeypox virus

Medical devices firm Trivitron Healthcare on Friday said it has developed a real-time PCR-based kit for the detection of Monkeypox virus, even as researchers are currently underway to understand the epidemiology, sources of spread, and the patterns..

Torrent Pharma acquires 4 Brands from Dr.Reddy's laboratories

Ahmedabad based Torrent Pharmaceuticals today announced that it has entered into an agreement with Dr. Reddy's Laboratories Ltd. to acquire four of its brands "Styptovit-E", "Finast", "Finast-T", and "Dynapress"...

Medley Pharma likely to be sold in Rs 5,000 crore

Medley Pharma, the privately held Mumbai-based firm, is on the block. Drug majors like Cipla, Dr Reddy’s, KKR-backed JB Chemicals, and Torrent, along with marquee private equity investors Advent, Carlyle and Blackstone are seen as potential buyers...

Roche develops monkeypox PCR tests

Swiss pharmaceutical giant Roche said Wednesday it had come up with PCR tests that can detect monkeypox, as the virus spreads outside endemic countries...

Moderna testing potential monkeypox vaccines

Moderna Inc is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe...

Pfizer to trade all its patented drugs at nonprofit price in low-income countries

Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's low-income countries, the drugmaker said on Wednesday....

Pfizer presents ELEVATE pivotal result demonstrating etrasimod's potentially best-n-class profile in ulcerative colitis

Pfizer Inc. announced detailed results from two pivotal studies that make up the ELEVATE UC phase 3 registrational programme evaluating etrasimod, a once-daily, oral, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment...

Indian vaccine giant Serum Institute plans African plant in worldwide expansion

The Serum Institute of India (SII), the world's largest vaccine maker, is considering setting up its first manufacturing plant in Africa as it looks to expand globally after its success in selling COVID-19 shots, its CEO told Reuters on Monday...

Pfizer & BioNTech say 3 COVID shots elicit good response in children under 5

Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial...

AstraZeneca's dapagliflozin meets primary endpoint in DELIVER phase III trial

Results from the DELIVER and DAPA-HF phase III trials demonstrate AstraZeneca’s dapagliflozin’ efficacy in heart failure regardless of ejection fraction. It reached a statistically significant and clinically meaningful reduction in the primary...

© 2025 India Pharma Outlook. All Rights Reserved.